论文部分内容阅读
目的探究吉西他滨配合中药治疗老年晚期非小细胞肺癌的治疗效果。方法将2008年10月至2010年12月我院接收治疗的78例老年晚期非小细胞肺癌患者,随机分为实验组和对照组,分别用吉西他滨配合中药治疗和单独吉西他滨治疗,记录两组患者病情的改变情况,不良反应发生情况,对比二者的治疗效果和不良反应。结果实验组和对照组患者的病情均好转,实验组患者的好转情况较对照组明显,有效率较对照组高,不良反应发生率低较对照组低。结论吉西他滨配合中药能有效治疗老年晚期非小细胞肺癌,起到“增效减毒”作用,是治疗老年晚期非小细胞肺癌的有效方法,值得在临床推广。
Objective To investigate the effect of gemcitabine combined with traditional Chinese medicine in the treatment of elderly patients with advanced non-small cell lung cancer. Methods Seventy-eight elderly patients with advanced non-small cell lung cancer receiving treatment from October 2008 to December 2010 in our hospital were randomly divided into experimental group and control group. Gemcitabine combined with traditional Chinese medicine and gemcitabine alone were used to treat the two groups of patients Changes in the condition, the occurrence of adverse reactions, the two compared the therapeutic effect and adverse reactions. Results The patients in the experimental group and the control group got better condition. The improvement of the experimental group was more obvious than that of the control group, the effective rate was higher than that of the control group, and the incidence of adverse reactions was lower than that of the control group. Conclusion Gemcitabine combined with traditional Chinese medicine can effectively treat elderly patients with advanced non-small cell lung cancer, play a “synergistic attenuated” role in the treatment of advanced non-small cell lung cancer is an effective method, worthy of clinical promotion.